对认知功能有负面影响的药物 (第二部分):在给CKD患者开处方时应考虑的药物类
Gaye Hafez1, Jolanta Malyszko2, Aleksandra Golenia3
1Department of Pharmacology, Faculty of Pharmacy, Altinbas University, Istanbul, Turkey.
Clinical kidney journal
|December 4, 2023
概括
慢性病 (CKD) 增加了认知障碍的风险. 本综述详细介绍了常见的药物,这些药物可以恶化CKD患者的认知功能.
科学领域:
- 腎臟病學 (nephrology) 是一種醫學專業.
- 神经学 神经学
- 药理学 药理学是指药理学的学科.
背景情况:
- 慢性病 (CKD) 越来越被认为是认知障碍的独立风险因素.
- 病理机制包括血管损伤,血脑屏障破坏和尿素毒素的积累.
- 慢性病患者通常由于伴随疾病而有复杂的药物治疗方案.
研究的目的:
- 审查与一般人群的认知障碍相关的常见药物,特别是CKD患者.
- 描述这些药物的对认知的影响.
主要方法:
- 对检查药物对一般认知和CKD人群影响的研究的文献综述.
- 分析经常用于CKD管理的药物类别及其已知或疑似对认知功能的影响.
主要成果:
- 几种药物类别,包括精神药物,抗胆固醇药物,GABAergic药物,阿片类药物和皮质类固醇,与认知障碍有关.
- 这些药物通常是CKD患者复杂治疗方案的一部分.
- 了解这些药物效应对于管理CKD认知健康至关重要.
结论:
- 通常为CKD患者处方的药物可能会加剧或导致认知障碍.
- 意识和精心选择药物对于减轻这一群体的认知风险至关重要.
- 需要进一步的研究来优化药物治疗策略,以保持CKD的认知功能.
相关概念视频
Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists
128
Cognitive enhancers, also known as "smart drugs," are substances used to enhance memory, mental alertness, and concentration. These can be natural or synthetic and improve cognition in conditions like Alzheimer's disease (AD) and other neurodegenerative diseases. Some common examples include caffeine, amphetamines, methylphenidate, modafinil, arecoline, donepezil, vortioxetine, and piracetam. These enhancers work on the principle of synaptic plasticity and altered circuit function.
128
Alzheimer's Disease: Treatment
195
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
195
Factors Affecting Renal Clearance: Renal Impairment
99
Renal dysfunction significantly impairs the renal clearance of drugs, leading to potential complications in drug therapy. Renal failure, which can be caused by various factors, poses a significant challenge in the elimination of drugs from the body.
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
99
Antiarrhythmic Drugs: Class I Agents as Sodium Channel Blockers
1.4K
Class I antiarrhythmic drugs are used to treat various types of arrhythmias or irregular heart rhythms. These drugs block the sodium (Na+) channels in the cardiac cells, thereby affecting the movement of electrical impulses across the heart. Class I antiarrhythmic drugs are divided into three subgroups: Class IA, Class IB, and Class IC, each with distinct mechanisms of action and effects on the heart.
Class 1A Antiarrhythmic Drugs: These drugs work by moderately blocking sodium channels,...
Class 1A Antiarrhythmic Drugs: These drugs work by moderately blocking sodium channels,...
1.4K
Drug Classes and Categories
2.0K
Drugs can be classified according to their chemical composition or their intended therapeutic application. For instance, anti-infective agents that possess the ability to eliminate pathogens or suppress their growth and reproduction can be grouped based on the organisms they target or their chemical structure. Furthermore, drugs can be divided into prescription, nonprescription, or controlled substances. Prescription medications, such as antibiotics, require oversight from a licensed healthcare...
2.0K
Renal Failure: Dose Adjustments
95
In patients with renal impairment, drugs undergo significant changes in their pharmacokinetics, which require dosage adjustments to ensure safe and effective therapy.
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
95


